Viewing Study NCT03383458


Ignite Creation Date: 2025-12-25 @ 12:07 AM
Ignite Modification Date: 2026-02-28 @ 2:29 PM
Study NCT ID: NCT03383458
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2017-12-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module